Drug Therapy for Coagulation Disorders Ch 7 E2 Flashcards
Anticoagulants
drugs that prevent formation of new clots and extension of clots already present; do not dissolve formed clots
Antiplatelets
drugs that prevent one or more steps in the prothrombotic activity of platelets
Embolus
object that migrates through the circulation until it lodges in a blood vessel, causing occlusion; may be a thrombus, fat, air, amniotic fluid, a bit of tissue, or bacterial debris
Essential thrombocythemia
chronic blood disorder characterized by the overproduction of platelets by megakaryocytes in the absence of another cause
Fibrinolysin
enzyme that breaks down the fibrin meshwork that stabilizes blood clots; also referred to as plasmin
Hemostasis
prevention or stoppage of blood loss from an injured blood vessel and is the process that maintains the integrity of the vascular compartment
Heparin-induced thrombocytopenia (HIT
immune-mediated prothrombotic reaction resulting in a decrease in platelet count associated with heparin administration in patients with detectable HIT antibodies
Plasmin
enzyme that breaks down the fibrin meshwork that stabilizes blood clots; also referred to as fibrinolysin
Plasminogen
inactive protein found in many body tissues and fluids
Prothrombotic reaction
adverse effect that leads to thrombogenesis
Thrombogenesis
formation of a blood clot
Thrombolysis
breakdown or dissolution of blood clots
Thrombolytics
drugs that dissolve blood clots
Thrombosis
formation of a blood clot
Thrombus
blood clot